ENSTILAR calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can Australia - English - Department of Health (Therapeutic Goods Administration)

enstilar calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can

leo pharma pty ltd - calcipotriol, quantity: 20.5 microgram/g; betamethasone dipropionate, quantity: 264 microgram/g (equivalent: betamethasone, qty 205 microgram/g) - foam - excipient ingredients: polyoxypropylene-11 stearyl ether; liquid paraffin; dl-alpha-tocopherol; white soft paraffin; butane; methyl ether - enstilar is indicated for the topical treatment of psoriasis vulgaris in adults.

ENSTILAR Israel - English - Ministry of Health

enstilar

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - cutaneous foam - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations - topical treatment of psoriasis vulgaris in adults

ENSTILAR Israel - English - Ministry of Health

enstilar

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - cutaneous foam - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations - topical treatment of psoriasis vulgaris in adults

GLENBEX Calcipotriol (as monohydrate) 50 microgram/g and Betamethasone (as dipropionate) 500 microgram/g Foam Aerosol Can Australia - English - Department of Health (Therapeutic Goods Administration)

glenbex calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can

freyr australia pty ltd - betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty 500 microgram/g); calcipotriol monohydrate, quantity: 52.2 microgram/g - foam - excipient ingredients: propane; polyoxypropylene-11 stearyl ether; isobutane; d-alpha-tocopherol; isopropyl alcohol; butane; white soft paraffin; liquid paraffin - topical treatment of psoriasis vulgaris in adults.

XAMIOL Israel - English - Ministry of Health

xamiol

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - gel - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

DAIVOBET Israel - English - Ministry of Health

daivobet

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ointment - betamethasone as dipropionate 0.5 mg/g; calcipotriol as hydrate 50 mcg/g - calcipotriol, combinations - calcipotriol, combinations - topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.

Calcipotriol/Betamethasone Sandoz Ointment 50mcg per g/ 500mcg per g Malta - English - Medicines Authority

calcipotriol/betamethasone sandoz ointment 50mcg per g/ 500mcg per g

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - calcipotriol monohydrate, betamethasone dipropionate - ointment - calcipotriol monohydrate 50 µg/g betamethasone dipropionate 0.5 mg/g - antipsoriatics

CALCIPOTRIOL/BETAMETHASONE SANDOZ 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

calcipotriol/betamethasone sandoz 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment tube

sandoz pty ltd - calcipotriol, quantity: 52.2 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty microgram/g) - ointment - excipient ingredients: dl-alpha-tocopherol; oleyl alcohol; liquid paraffin; white soft paraffin - indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.

DAIVOBET 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel bottle Australia - English - Department of Health (Therapeutic Goods Administration)

daivobet 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel bottle

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate (equivalent: betamethasone, qty 500 microgram/g) - gel - excipient ingredients: nitrogen; hydrogenated castor oil; polyoxypropylene-11 stearyl ether; butylated hydroxytoluene; liquid paraffin; dl-alpha-tocopherol - topical treatment of scalp psoriasis. topical treatment of mild to moderate plaque psoriasis on the body in adults.

DAIVOBET 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

daivobet 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment tube

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty 500 microgram/g) - ointment - excipient ingredients: liquid paraffin; polyoxypropylene-11 stearyl ether; dl-alpha-tocopherol; white soft paraffin; butylated hydroxytoluene - daivobet ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.